Alkeus Pharmaceuticals Announces Presentation of a TEASE-3
CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced the presentation of interim data from its ...
Read moreCAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced the presentation of interim data from its ...
Read moreSAN DIEGO and SUZHOU, China, July 12, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the ...
Read moreTORONTO and HAIFA, Israel, July 05, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the ...
Read moreCompany to Host Webcast on 12th July at 9am AEST (7pm ET, 11 July) SYDNEY, AUSTRALIA, July 03, 2024 (GLOBE ...
Read moreBOSTON, June 21, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease ...
Read morePRINCETON, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- Origin Life Sciences, Inc., a clinical-stage biotechnology company developing a proprietary patented ...
Read moreNEW YORK, June 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), Chief Executive Silviu Itescu provided a corporate update ...
Read moreVALENCIA, Spain, May 30, 2024 (GLOBE NEWSWIRE) -- Under the theme "Revolutionizing Patient Care through the Power of Data Science," ...
Read moreMironid Presents Translational Data in Oral Presentation at the European Renal Association Congress LoAc® compound lowers renal cAMP after single ...
Read moreFollow-up results from Phase 3 study on SB16: switching period up to Month 18Study shows SB16 comparable with reference denosumab ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.